Other · developed by Protalix
AIR DNase is an inhaled deoxyribonuclease formulation studied in cystic fibrosis, a chronic respiratory disease.
Summary written with AI from the sources listed at the end of this page.
| Trial | Phase | Condition | Status | Sponsor |
|---|---|---|---|---|
| NCT02722122 | Phase 2 | Cystic Fibrosis | Unknown | PLX |
| NCT02605590 | Phase 1 | Cystic Fibrosis (CF) | Completed | PLX |
Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.
Cystic FibrosisCystic Fibrosis (CF)
See PLX's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.
PLX catalysts and pipeline →